5-[2-(8-羟基喹啉-2-基)乙烯基]-2-甲基-8-羟基喹啉的合成、抗氧化活性及促进鼠骨髓间质干细胞增殖的研究

设计合成了5-[2-(8-羟基喹啉-2-基)乙烯基]-2-甲基-8-羟基喹啉(5), 用IR, UV, ¹H NMR, MS和元素分析确认其结构. 利用DPPH•法和噻唑蓝比色法(MTT法)分别测定了目标产物的抗氧化活性及调控鼠骨髓间质干细胞(MSCs)增殖的作用. 结果表明, 目标产物有较强的抗氧化活性, 在低浓度时对鼠骨髓间质干细胞有促进作用.     

8-羟基喹啉衍生物及其金属配合物的合成与光致发光特性

设计合成了三种新型的8-羟基喹啉衍生物配体: 5-[(4-E-苯乙烯基)-苯甲亚胺基]-8-羟基喹啉(1), 5-[(4-溴-2-氟)-苯甲亚胺基]-8-羟基喹啉(2)和N-乙基-3-[2-(8-羟基喹啉基)-乙烯基]咔唑(3), 以及它们相应的金属配合物, 产物经质谱(MS)、元素分析(EA)、红外光谱(IR)、紫外光谱(UV)、核磁共振氢谱(¹H NMR)进行表征, 并测定了它们的荧光性质. 结果与8-羟基喹啉比较表明, 5位和2位取代8-羟基喹啉衍生物的荧光发生了明显的红移. 同时测定了配合物(3)₂Zn的荧光寿命, 结果表明, N-乙基-3-[2-(8-羟基喹啉基)-乙烯基]咔唑锌配合物表现出较长的荧光寿命.     

2-甲基-2,5′-(乙烯基)-二-8-羟基喹啉锌配合物的合成与荧光特性

设计合成了8-羟基喹啉衍生物3和4以及它们的金属锌配合物5和6,化合物3和4经质谱(MS)、元素分析(EA)、红外光谱(IR)、紫外光谱(UV)、核磁共振氢谱( ¹H NMR)进行表征,并测定了它们的荧光性质,与2-甲基-8-羟基喹啉(λ_max=390 nm)比较表明,化合物3和4的荧光红移80～150 nm;用X射线单晶衍射仪测定了化合物3的晶体结构,晶体属于三斜晶系,空间群P1,a=0.706 87(5) nm,b=0.962 03(6) nm,c=1.221 09(8) nm,α=86.735(4)°,β=87.840(4)°,γ=74.333(4)°,V=0.798 01(9) nm³,Z=2,D_c=1.367 Mg·m^-3,μ=0.089 mm^-1,F(000)=344,wR₁=0.055 2,wR₂=0.158 1。化合物3的晶体结构确认了2-甲基-8-羟基喹啉甲酰化是在5位。测定了化合物5和6的荧光光谱及其荧光寿命,结果表明,化合物5和6发光的峰值为620 nm 和623nm,能够发出橙色的荧光,与2-甲基-8-羟基喹啉锌(λ_max=515 nm)比较,发生了明显的红移。化合物5和6的寿命分别为1.57 ns和1.77 ns,呈单指数衰减。     

手性3,5-二甲基-2-芳基-2-吗啉醇盐酸盐的合成及其晶体结构

以(S)-2-氨基丙醇为手性源与α-溴-3-氯苯丙酮反应, (R)-2-氨基丙醇为手性源与6-甲氧基-2-(2-溴丙酰基)萘反应, 分别合成了手性纯化合物(2R,3R,5S)-3,5-二甲基-2-(3-氯苯基)-2-吗啉醇盐酸盐(4a)和(2S,3S,5R)-3,5-二甲基-2-(6-甲氧基-2-萘基)-2-吗啉醇盐酸盐(4b), 利用X射线单晶衍射仪测定了两化合物的晶体结构和两化合物的空间结构, 并初步分析两化合物空间结构, 化合物4a晶体属正交晶系, 空间群为P2₁2₁2, 晶胞参数为: a＝0.8718(2) nm, b＝0.7883(2) nm, c＝2.0247(6) nm, Z＝4, V＝1.3915(7) nm³, D_c＝1.328 g/cm³, F(000)＝584, R₁＝0.0399, wR₂＝0.0797, S＝1.042. 化合物4b晶体属正交晶系, 空间群为P2₁2₁2₁, 晶胞参数为: a＝0.71035 (9) nm, b＝0.77703(10) nm, c＝2.9820(4) nm, Z＝4, V＝1.6318(4) nm³, D_c＝1.318 g/cm³, F(000)＝688, R₁＝0.0520, wR₂＝0.1108, S＝0.994.     

含三唑基的新型咪唑[2,1-b]-1,3,4-噻二唑的合成及表征

以2-(2-苯基-1,2,3-三唑-4-基)-5-氨基-1,3,4-噻二唑(1)为原料分别与ω-溴代芳基乙酮、ω-溴代-ω-(1H-1,2,4-三唑-1-基)芳基乙酮反应, 合成了一系列新型咪唑[2,1-b]-1,3,4-噻二唑类化合物2a～2e和3a～3e. 其结构经IR, ¹H NMR和MS及元素分析确证.     

3,5-二(吡啶-4-甲氧基)苯甲酸和芳香二羧酸配体构建的具有3,4-连接四重和三重穿插的d10金属配位聚合物

以3,5-二(吡啶-4-甲氧基)苯甲酸(HL)与芳香二羧酸为配体,在水热条件下与Zn(Ⅱ)或Cd(Ⅱ)盐反应得到4个具有3,4-连接多重穿插结构的配位聚合物:[Zn₂L₂(tdc)]_n (1),{[Zn₄L₄(Hhdc)₂]·H₂O}_n (2),{[Zn₂L₂(Hhdc)]·H₂O}_n (3),{[Cd₂L₂(bdtc)(H₂O)]·0.5H₂O}_n (4)(H₂tdc=2,5-噻吩二甲酸,H₃hdc=5-羟基间苯二甲酸,H₂bdtc=1,4-苯二硫乙酸).晶体结构分析表明,聚合物1~3具有3,4-连接四重穿插的三维网络结构,拓扑符号分别为(4.8²)(4.8⁵) (1)、(6³)(6⁵.8) (2)和(6³)(6⁵.8) (3).4为3,4-连接三重穿插的二维平面结构,拓扑符号为(63)(66).测定了配位聚合物1、3和4的热稳定性和荧光性质.     

5-硝基-2H-四唑的合成、反应性及产物晶体结构的研究

5-氨基四唑(1)经过重氮化反应得到5-硝基四唑(5), 5与甲醛反应得到2-羟甲基-5-硝基四唑(6), 6与HCl或HBr反应分别得到5-5氯代四唑(7)和5-溴代四唑(8), 采用MS, IR, ¹H NMR, ¹³C NMR等技术对这些化合物进行了表征. 用X射线单晶衍射法测定了化合物5-硝基四唑钠(4), 5和6的晶体结构. 化合物4属于三斜晶系, P-1空间群; 化合物 5和6均属于单斜晶系, P2₁空间群, 化合物6的晶胞参数a＝0.66131(18) nm, b＝0.54905(15) nm, c＝0.7566(2) nm, Z＝2, V＝0.27470(13) nm³, D_c＝1.754 g/cm³, F(000)＝128, μ＝0.160 mm^－1.     

基于2-甲基-8-羟基喹啉的镝单分子磁体的晶体结构及磁性

以2-甲基-8-羟基喹啉(HL)为配体合成了2个含有镝离子的配位化合物[Dy₂L₄(HL)₄(H₂O)₂](ClO₄)₂·2H₂O(1)和[Dy₂L₆(C₂H₅OH)]·H₂O(2)。虽然在这两个配位化合物中配体都是2-甲基-8-羟基喹啉,但其参与配位的方式不同。这导致2个化合物中镝离子所处的配位环境不同,进而对化合物的磁性产生了影响。     

基于2-氨基-3-羟基-吡啶Schiff碱的双核Ni(Ⅱ)和Zn(Ⅱ)配合物:合成、超分子结构和光谱性质

合成了2个2-氨基-3-羟基-吡啶Schiff碱双核Ni（Ⅱ）和Zn（Ⅱ）配合物,[Ni（L¹）（DMF）]₂（1）（H₂L¹=4-羟基-3-（（3-羟基-吡啶-2-亚氨基））-苯并吡喃-2-酮）和[Zn（L²）（H₂O）]2·2DMF（2）（H₂L²=2-（（3,5-二溴-2-羟基）-氨基）-吡啶-3-醇）,并通过元素分析、红外光谱、紫外-可见吸收光谱、荧光光谱及X射线单晶衍射分析等手段进行了表征。X射线单晶衍射分析结果表明：配合物1和2均具有双核结构,均由2个金属离子和2个配体单元以及2个配位的溶剂分子组成,不同的是配合物2含有2个溶剂分子。配合物1和2都是单斜晶系、P2₁/c空间群,且中心金属Ni（Ⅱ）和Zn（Ⅱ）离子的空间构型均为五配位的扭曲的四方锥。此外,配合物1和2通过分子间氢键、C-H…π及π…π作用形成3D超分子结构。此外,讨论了H₂L¹,H₂L²及其相应的Ni（Ⅱ）和Zn（Ⅱ）配合物的荧光性质。配体H₂L¹和H₂L²呈现蓝色发射,最大发射波长λ_em分别为457和473 nm,而配合物1和2显示绿色发射,λ_em分别为543和538 nm。     

新型3-取代-6-(4-氯苯基)-7-(1H-1,2,4-三唑-1-基)-1',2',4'-三唑[3,4-b]-1",3",4"-噻二嗪衍生物的合成及抗菌活性

通过3-取代-4-氨基-5-巯基-1,2,4-三唑(3a～3m)和2-溴-2-(1H–1,2,4-三唑-1-基)-4′-氯代苯乙酮(2)的缩合反应, 合成了13个新型3-取代-6-(4-氯苯基)-7-(1H-1,2,4-三唑-1-基)-1',2',4'-三唑[3,4-b]-1",3",4"-噻二嗪衍生物4a～4m. 化合物结构经元素分析, ¹H NMR, IR和MS进行了表征. 抗菌试验表明所合成的化合物对细菌表现出中等程度的抑制活性.     

Synthesis and crystal structures of three new complexes derived from 3-(pyridin-3′-yl)-5-(pyridin-2′′-yl)-1,2,4-triazole

Three new coordination complexes, [Cd₂(ppt)₂(cpba)]?·?(H₂O)₂ (1), [Zn(ppt)₂]?·?(H₂O) (2), and [Zn(MoO₄)(Hppt)] (3) (H₂cpba: 3-(2′-carboxy-phenoxy)-benzoic acid; Hppt: 3-(pyridin-3′-yl)-5-(pyridin-2′′-yl)-1,2,4-triazole), were synthesized under hydrothermal conditions. Their structures have been determined by single crystal X-ray diffraction analyses and further characterized by elemental analyses, IR spectra, and thermogravimetric analyses. X-ray diffraction analyses revealed that Cd(II) ions are linked by ppt^? to form a ladder-shaped structure along the a-axis and further displays a 2-D supramolecular architecture with cpba^2? along the c-axis. In 2, each Zn(ppt)₂ fragment is linked by the nitrogen of pyridin-3′-yl from the neighboring Zn(ppt)₂ forming a V-shaped chain. Compound 3 consists of a ladder structure, in which each {MoO₄} unit is a bridge linking three Zn(Hppt)²⁺ fragments.     

二{2-{2-{9-乙基-6-[2-(8-羟基喹啉-2-基)乙烯基]咔唑-3-基}乙烯}-8-羟基喹啉}锌配合物的合成与荧光光谱特性

合成了新的N-乙基咔唑衍生物: 3,6-二[2-(8-羟基喹啉基)乙烯基]咔唑(4)及其锌配合物(5); 化合物4经质谱、红外光谱、核磁共振氢谱、元素分析表征其结构, 并测定了它的荧光光谱. 结果显示: 化合物4的荧光发射为蓝绿色光(500 nm), 其发射光谱随着溶剂极性的增大荧光光谱向长波方向移动(即发生红移); 同时, 考察了化合物5的荧光性质, 其荧光发光峰值为600 nm, 与2-甲基-8-羟基喹啉锌相比, 发生了明显的红移.     

Synthesis,structures, and urease inhibition of nickel(II), zinc(II), and cobalt(II) complexes with similar hydroxy-rich Schiff bases

Four new nickel(II), zinc(II), and cobalt(II) complexes, [Zn(L¹)₂]?·?H₂O (1), [Ni(L¹)₂]?·?H₂O (2), [Ni(L²)₂] (3), and [Co(L³)₂]?·?H₂O (4), derived from hydroxy-rich Schiff bases 2-{[1-(5-chloro-2-hydroxyphenyl)methylidene]amino}-2-methylpropane-1,3-diol (HL¹), 2-{[1-(2-hydroxy-3-methoxyphenyl)methylidene]amino}-2-ethylpropane-1,3-diol (HL²), and 2-{[1-(5-bromo-2-hydroxyphenyl)methylidene]amino}-2-methylpropane-1,3-diol (HL³) have been synthesized and characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray determination. Each metal in the complexes is six-coordinate in a distorted octahedral coordination. The Schiff bases coordinate to the metal atoms through the imino N, phenolate O, and one hydroxyl O. In the crystal structures of HL¹ and the complexes, molecules are linked through intermolecular O–H···O hydrogen bonds, forming 1-D chains. The urease inhibitory activities of the compounds were evaluated and molecular docking study of the compounds with the Helicobacter pylori urease was performed.     

A bifunctional 2,2′:6′,2″-terpyridine-based ligand for ratiometric Cu(II) sensing

Synthesis and characterization of the bifunctional sensor receptor ligand N-([2,2′:6′,2″-terpyridine]-4′-yl)methyl)-N-propylacrylamide (1) and the model ligand N-([2,2′:6′,2″-terpyridine]-4′-yl)methyl)-N-propylisobutyramide (2) are described. Ligand 1 is a receptor for Cu(II) that is copolymerizable with N-isopropylacrylamide giving a ratiometric sensor of weakly bound Cu(II) in environmental waters. Ligand 2 is a model for copolymerized 1 whereby the reactive acrylamide group is replaced by isobutyramide. Solution speciation of complexes of Cu(II) and Zn(II) with 2 were investigated spectroscopically and their solid-state structures were studied through single-crystal X-ray diffraction. Solution UV–vis and fluorescence studies show a preference of 2 toward Cu(II) over Na(I), Zn(II), Cu(II), Co(II), Mn(II), Ni(II), Cd(II), and Pb(II) in accord with the Irving–Williams series and other coordination principles. Solution speciation determined in a weakly coordinating aqueous-organic (60?:?40 DMF/H₂O) medium indicates 1?:?1 Cu(II):2 binding as desired in that formation of [Cu(2)₂]²⁺ would crosslink the polymer sensor. The crystal structures of [Cu(2)(NO₃)₂] and [Zn(2)(NO₃)₂]·MeOH·1/2Et₂O display distorted octahedral geometries where 2 coordinates meridionally and two nitrate groups occupy the remaining sites around the metal center.     

Cobalt(II), nickel(II) and zinc(II) coordination compounds derived from aromatic amines

The structural and spectroscopic characterization of coordination compounds of four aromatic amines derived from benzimidazole, 2-aminobenzimidazole (L1), 1-(S-methylcarbodithioate)-2-aminobenzimidazole (L2), 2-(2-aminophenyl)-1H-benzimidazole (L3) and 6,6-dimethyl-5H-benzimidazolyl[1,2-c]quinazoline (L4) are reported. Cobalt(II) [Co(L1)₂(CH₃COO)₂] (1) and nickel(II) [Ni(L1)₂(CH₃COO)₂] (2) acetate coordination compounds of L1 are discussed. The synthesis and the X-ray crystal structure of the new 1-(S-methylcarbodithioate)-2-aminobenzimidazole (L2) is informed, together with its cobalt(II) [Co(L2)₂Cl₂] (3), [Co(L2)₂Br₂] (4) and zinc(II) [Co(L2)₂Cl₂] (5), [Zn(L2)₂Br₂] (6) coordination compounds. In these compounds the imidazolic nitrogen is coordinated to the metal center, while the ArNH₂ and the S-methylcarbodithioate groups do not participate as coordination sites. A co-crystal of L1 and L2 is analyzed. Structural analyses of the coordination compounds of L3 showed that this ligand behaves as a bidentate ligand through the aniline and the imidazole groups forming six membered rings in the cobalt(II) [Co(L3)Cl₂] (7) and zinc(II) [Zn(L3)Cl₂] (8) compounds, as well as the nickel(II) nitrate [Ni(L3)₂(H₂O)₂](NO₃)₂ (9). The quinazoline L4 was produced by insertion of one acetone molecule and water elimination in L3, its X-ray crystal diffraction analysis, as well as that of its zinc(II) coordination compound [Zn(L4)₂Cl₂] (10), are discussed.     

Syntheses,structures, and luminescence of two Zn(II) coordination polymers based on 5-(4-imidazol-1-yl-phenyl)-2H-tetrazole and carboxylates

Reactions of Zn(II) salts, 5-(4-(1H-imidazol-1-yl)phenyl)-1H-tetrazolate (HIPT) and 2-mercaptobenzoic acid or 2-propyl-1H-imidazole-4,5-dicarboxylic acid (H₃PrIDC), result in two mixed-ligand coordination polymers (CPs), [Zn₂(IPT)(DSDB)(OH)]_n (H₂DSDB = 2,2′-disulfanediyldibenzoic acid, 1) and [Zn₂(IPT)(PrIDC)(H₂O)]_n (H₃PrIDC = 2-propyl-1H-imidazole-4,5-dicarboxylic acid, 2). Compound 1 possesses a 2-D structure built by 1-D [Zn(IPT)]_n chains and DSDB^2? connectors, in which the DSDB^2? is generated via in situ reaction from 2-mercaptobenzoic acid. It displays a new intricate 4-nodal {3·4·6·7·8·9}{3·6·7·8·9·10}{3·8·9}{4·6·8} topology. Compound 2 displays a 3-D framework with new 3-connected topology with Schläfli symbol of (4·8·10) (8·12²), in which the 1-D Zn-carboxylate chains were bridged by 3-connected IPT^? ligands. The thermal stabilities and luminescence properties of 1 and 2 have also been studied. The compounds exhibit intense solid-state fluorescent emissions at room temperature.     

Zn(II) Complexes with Quinoline Supported Amidate Ligands: Synthesis,Fluorescence, and Catalytic Activity

Zn(II) complexes of N-(quinolin-8-yl)picolinamide (HL¹) (1) and N²,N⁶-di(quinolin-8-yl)pyridine-2,6-dicarboxamide (H₂L²) (2) have been synthesized by deprotonation of the ligands and characterized by IR, NMR, and Single crystal X-ray crystallography. The mononuclear [Zn(L¹)₂] (3) and homodinuclear [Zn₂(L²)₂] (4) complexes are characterized by distorted octahedral geometries stabilized by hydrogen bonding and weak π···π interaction. The complexes demonstrate intense fluorescence bands in comparison with their corresponding ligands with well-distinguished intensity. The complexes act as efficient catalysts in various transesterification reactions. Among those, the best results have been achieved with complex 3 in conversion of 4-nitrophenylacetate into methyl acetate within 3 h.

     

(E)-N-芳基-3-[2-(8-羟基喹啉基)-乙烯基]咔唑的合成、抗氧化活性及促进鼠骨髓间质干细胞增殖的研究

设计合成了3-[2-(8-羟基喹啉基)-乙烯基]-N-对甲苯基咔唑(8)和3-[2-(8-羟基喹啉基)-乙烯基]-N-对甲氧苯基咔唑(9)两个新的化合物, 用IR, MS, 1H NMR和元素分析确认其结构. 并利用DPPH•方法, 超氧阴离子自由基( )法, 羟基自由基HO•法和噻唑蓝比色法(MTT法)分别测定了目标产物的抗氧化活性和调控鼠骨髓间质干细胞(MSCs)的作用. 结果表明, 这两种化合物对DPPH•自由基、超氧阴离子自由基和羟基自由基具有较强的抗氧化活性, 化合物9在低浓度时对鼠骨髓间质干细胞增殖有很好的促进作用.     

Hypervalent triphenyl and diphenyl tin coordination compounds derived from 2-(1H-benzimidazol-2-yl)phenol

Reactions of 2-(1H-benzimidazol-2-yl)phenol (1) and SnPh₃Cl, SnPh₂Cl₂ and SnCl₄ were investigated. One tetracoordinated triphenyltin(IV) compound: triphenyltin-2-(1H-benzimidazol-2-yl)phenolate] (3) and its adducts: [O → Sn] dimethylsulfoxide triphenyltin-[2-(1H-benzimidazol-2-yl)phenolate] (4), [O → Sn] aqua triphenyltin-[2-(1H-benzimidazol-2-yl)phenolate] (5) [O → Sn] ethanol triphenyltin-[2-(1H-benzimidazol-2-yl)phenolate] (6), [N → Sn] pyridine triphenyltin-[2-(1H-benzimidazol-2-yl)phenolate] (7), where 1 acts as a monodentate ligand bound through the phenol oxygen, were obtained. In the pentacoordinated compounds 4-7, the tin atom has tbp geometry. The three phenyl groups are in equatorial positions, whereas the benzimidazole and the Lewis base are in apical positions. Two hexacoordinated tin compounds: diphenyltin-bis[2-(1H-benzimidazol-2-yl-κN)phenolate-κO] (8), dichlorotin-bis[2-(1H-benzimidazol-2-yl-κN)phenolate-κO] (9) bearing two bidentate ligands are reported. The coplanar ligands in 8 and 9 form six membered rings by oxygen and nitrogen coordination. The tin geometry is all-trans octahedral. In 8 the two phenyl groups, and in 9 the two chlorine atoms are perpendicular to the plane of the ligands. Compounds were identified in solution mainly by ¹H, ¹³C and ¹¹⁹Sn NMR and in the solid state by X-ray diffraction analysis.